ATTR-CM is an underdiagnosed, progressive, and infiltrative disease that can often be overlooked as a cause of heart failure.1,2
Prognosis worsens rapidly with continued amyloid deposition, resulting in advancing organ dysfunction, significant reduction in quality of life, and, ultimately, death.1,4
Heart failure with preserved ejection fraction, especially in patients older than 60 years, warrants evaluation by a cardiologist.5,6
Untreated patients have a median survival of ~2 to 3.5 years once diagnosed with ATTR-CM.4
Gain a deeper understanding of echocardiography and cardiac magnetic resonance (CMR).
Review the evidence and consensus recommendations for diagnosis.
The CARE program features a variety of educational materials for cardiologists as well as content intended to educate patients about ATTR-CM and aid in the process of referral to a specialist.
Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Adverse events should also be reported to Pfizer Medical Information on 1800 633 363
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.
Copyright © 2023 Pfizer Limited. All rights reserved.
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023